Kyzatrex FDA Approval Status
FDA Approved: No
Brand name: Kyzatrex
Generic name: testosterone undecanoate
Company: Marius Pharmaceuticals
Treatment for: Hypogonadism, Male
Kyzatrex (testosterone undecanoate) is a novel, soft gelatin capsule testosterone formulation in development for the treatment of primary and secondary hypogonadism in adult men.
Development Timeline for Kyzatrex
|Jan 5, 2021||Marius Pharmaceuticals Submits New Drug Application to U.S. FDA for Kyzatrex Next-generation Oral Testosterone Replacement Therapy in Male Patients with Hypogonadism|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.